Chemotherapy-Induced Neuropathy in Cancer Survivors

Read this article on the Journal of Pain and Symptom Management website.

Publication Details
Miaskowski, C RN, PhD, Mastick, J RN, MN, Paul SM, PhD, Topp, K PT, PhD, Smoot, B PT, DPTSc, Abrams, G MD, Chen, L MD, Kober, KM PhD, Conley, YP PhD, Chesney, M PhD, Bolla, K RN, BSN, Mausisa, G RN, MS, Mazor, M RN, PhD(c), Wong, M MD, Schumacher, M MD, PhD, and Levine, JD MD, PhD Journal of Pain and Symptom Management, August 2017

Study Information
Risk Factors for Breast Cancer Lymphedema

The purpose of this study at the University of California, San Francisco is to better understand the signs and symptoms of chemotherapy neuropathy and the genetic (inherited) factors that increase risk of developing it. The researchers wanted to enroll up to 600 volunteers near San Francisco and they enlisted the Love Research Army (LoveRA) to support the final stages of their recruitment efforts. The Call to Action for this study was sent to LoveRA members on June 10, 2015, and the researchers closed enrollment on Nov. 23, 2015, after the LoveRA provided them with 106 women who were interested in enrolling in the study.

En Español »